Venus Medtech (Hangzhou) Inc. (2500.HK) HKSE

1.34

+0.04(+3.08%)

Updated at June 03 03:21PM

Currency In HKD

Valuation

Market Cap936.1M
Enterprise Value977.49M
P/E Ratio-1.24
PEG Ratio-0.02
Price/Sales Ratio1.66
Price/Book Ratio0.29
Enterprise/Revenue1.8
Enterprise/EBITDA-1.65

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-1.33
Operating Margin-1.13

Management Effectiveness

Return On Assets-0.16
Return On Equity-0.21

Income Statement

Revenue306.79M
Revenue/Share0.7
Gross Profit211.83M
EBITDA-315.42M
Net Income-407.69M
Diluted EPS-0.93

Balance Sheet

Total Cash280.52M
Total Cash/Share0.64
Total Debt216.43M
Total Debt/Equity0.12
Current Ratio2.77
Book Value Per Share4.03

Price History

52-Week Change-45.53
52-Week High5.47
52-Week Low1.16
Moving Average 50 Days1.81
Moving Average 200 Days2.63

Statistics

Average Volume1.13M
Shares Outstanding441.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A